Madge K. Shafmaster Buys 60,000 Shares of ProMIS Neurosciences, Inc. (NASDAQ:PMN) Stock

ProMIS Neurosciences, Inc. (NASDAQ:PMN) Director Madge K. Shafmaster bought 60,000 shares of the company’s stock in a transaction dated Friday, September 20th. The stock was purchased at an average cost of $1.25 per share, for a total transaction of $75,000.00. Following the completion of the acquisition, the director now owns 68,333 shares in the company, valued at approximately $85,416.25. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

ProMIS Neurosciences Stock Up 0.8 %

Shares of NASDAQ PMN opened at $1.31 on Thursday. The business’s 50 day moving average price is $1.39 and its two-hundred day moving average price is $1.71. The company has a market cap of $24.84 million, a PE ratio of -1.77 and a beta of 0.62. ProMIS Neurosciences, Inc. has a twelve month low of $0.95 and a twelve month high of $3.10.

ProMIS Neurosciences (NASDAQ:PMN) last issued its earnings results on Thursday, August 8th. The company reported ($0.13) EPS for the quarter, topping the consensus estimate of ($0.14) by $0.01. As a group, research analysts anticipate that ProMIS Neurosciences, Inc. will post -0.24 EPS for the current fiscal year.

ProMIS Neurosciences Company Profile

ProMIS Neurosciences, Inc discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins.